Nearly 80% of Patients with Moderate-to-Severe Atopic Dermatitis Maintained Clear or Almost Clear Skin with Lilly's Lebrikizumab Monthly Maintenance Dosing at Two Years
INDIANAPOLIS, Oct. 20, 2023 /PRNewswire/ -- Patients with moderate-to-severe atopic dermatitis who continued treatment with investigational lebrikizumab for up to two years experienced sustained skin clearance, itch relief and reduced disease... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 20, 2023 Category: Pharmaceuticals Source Type: clinical trials
Nanoformed TargTex Oncology Drug Candidate TTX101 Receives FDA Orphan Drug Designation
Helsinki, Finland October 19, 2023– Nanoform Finland Plc (Nasdaq Helsinki NANOFH; Nasdaq Stockholm NANOFS), an innovative nanoparticle medicine enabling company, today announced its customer TargTex S.A. has been granted Orphan Drug... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 19, 2023 Category: Pharmaceuticals Source Type: clinical trials
FDA Grants Fast Track Designation to ANPD001, Autologous Investigational Cell Therapy for the Treatment of Parkinson's Disease
SAN DIEGO, Oct. 19, 2023 /PRNewswire/ -- Aspen Neuroscience today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for ANPD001 for the treatment of Parkinson ' s disease (PD) to improve motor function.... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 19, 2023 Category: Pharmaceuticals Source Type: clinical trials
Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel ® (darvadstrocel) in Complex Crohn’s Perianal Fistulas
OSAKA, Japan, October 18, 2023, and CAMBRIDGE, Massachusetts, October 17, 2023 -- Takeda (TSE:4502/NYSE: TAK) today announced that the Phase 3 ADMIRE-CD II study, assessing the efficacy and safety of Alofisel® (darvadstrocel) for the treatment... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 17, 2023 Category: Pharmaceuticals Source Type: clinical trials
Clinical Trial Finds Live Vaccinations Safe for Liver, Kidney Transplant Recipients
CINCINNATI, Oct. 16, 2023. Live vaccinations provided to children who previously received liver or kidney transplants were found to be safe and prompted an immune response to guard against several life-threatening conditions, according to a new... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - October 17, 2023 Category: Pharmaceuticals Source Type: clinical trials
